GlobalData on MSN14d
Bavarian eyes Mpox vaccine label expansion to include toddlers, kickstarts Phase II trial
The registrational trial is expected to support the Bavarian’s mpox/smallpox vaccine use in children between 2 and 11 years ...
manilatimes15d
First Children Vaccinated in New Clinical Study Seeking to Expand the Indication for Bavarian Nordic's Mpox Vaccine
Results from this study could support an extension of the current approval of MVA-BN to include children from 2 years of age ...
Finanznachrichten15d
Bavarian Nordic A/S: First Children Vaccinated in New Clinical Study Seeking to Expand the Indication for Bavarian Nordic's Mpox Vaccine
adopting the recent approval from the European Medicines Agency (EMA) for this age group. Paul Chaplin, President & CEO of Bavarian Nordic, said: "Children remain highly vulnerable to mpox ...
Yahoo Finance27d
Bavarian Nordic’s mpox vaccine equally effective in teens as adults
A clinical trial by the US National Institutes of Health (NIH) has shown that Bavarian Nordic’s mpox vaccine induced an antibody response in adolescents equivalent to that of adults. The interim ...
Mena FN15d
First Children Vaccinated In New Clinical Study Seeking To Expand The Indication For Bavarian Nordic’S Mpox Vaccine
adopting the recent approval from the European Medicines Agency (EMA) for this age group. Paul Chaplin, President & CEO of Bavarian Nordic , said:“Children remain highly vulnerable to mpox ...
Pharmaceutical Technology27d
Bavarian Nordic’s mpox vaccine equally effective in teens as adults
Bavarian Nordic won an European Medicines Agency (EMA) approval for MVA-BN’s use in adolescents in September this year, whilst in the US it is still only approved in adults under the brand name ...
Seeking Alpha6d
Emergent BioSolutions Inc. (EBS) Q3 2024 Earnings Call Transcript
We are due $30 million from Bavarian Nordic as payment of the first few milestones triggered on acceptance by the EMA and FDA of the Chikungunya vaccine license applications. NARCAN volume ...